As of May 31, 2025, Recordati Industria Chimica e Farmaceutica SpA (REC.MI) reports a ROA (Return on Assets) of 8.11%.
ROA (Return on Assets) evaluates how effectively a company turns its assets into profits, showcasing resource utilization.
Historical Trend of Recordati Industria Chimica e Farmaceutica SpA's ROA (Return on Assets)
Over recent years, Recordati Industria Chimica e Farmaceutica SpA's ROA (Return on Assets) has shown a moderate pattern. The table below summarizes the historical values:
| Date | ROA (Return on Assets) |
|---|---|
| 2024-12-31 | 8.11% |
| 2023-12-31 | 9.25% |
| 2022-12-31 | 7.81% |
| 2021-12-31 | 13.71% |
| 2020-12-31 | 13.09% |
This slight downward trend highlights how Recordati Industria Chimica e Farmaceutica SpA manages its efficiency in using assets to generate earnings over time.
Comparing Recordati Industria Chimica e Farmaceutica SpA's ROA (Return on Assets) to Peers
To better understand Recordati Industria Chimica e Farmaceutica SpA's position, it's useful to compare its ROA (Return on Assets) against industry peers. Below are selected comparisons:
| Company | ROA (Return on Assets) |
|---|---|
| Recordati Industria Chimica e Farmaceutica SpA (REC.MI) | 8.11% |
| Cosmo Pharmaceuticals NV (COPN.SW) | 20.60% |
| Orion Oyj (ORNBV.HE) | 20.25% |
| Vectura Group PLC (VEC.L) | 18.38% |
| Laboratorios Farmaceuticos ROVI SA (ROVI.MC) | 16.45% |
| Richter Gedeon Vegyeszeti Gyar Nyrt (RICHTER.BD) | 14.92% |
Compared to its competitors, Recordati Industria Chimica e Farmaceutica SpA's ROA (Return on Assets) is about average compared to peers, indicating typical asset efficiency for the industry.